These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38499553)

  • 21. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
    Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
    Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme.
    Caval V; Bouzidi MS; Suspène R; Laude H; Dumargne MC; Bashamboo A; Krey T; Vartanian JP; Wain-Hobson S
    Nucleic Acids Res; 2015 Oct; 43(19):9340-9. PubMed ID: 26384561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small-Angle X-ray Scattering Models of APOBEC3B Catalytic Domain in a Complex with a Single-Stranded DNA Inhibitor.
    Barzak FM; Ryan TM; Kvach MV; Kurup HM; Aihara H; Harris RS; Filichev VV; Harjes E; Jameson GB
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33673243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOBEC3B Nuclear Localization Requires Two Distinct N-Terminal Domain Surfaces.
    Salamango DJ; McCann JL; Demir Ö; Brown WL; Amaro RE; Harris RS
    J Mol Biol; 2018 Aug; 430(17):2695-2708. PubMed ID: 29787764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes.
    Sanchez A; Ortega P; Sakhtemani R; Manjunath L; Oh S; Bournique E; Becker A; Kim K; Durfee C; Temiz NA; Chen XS; Harris RS; Lawrence MS; Buisson R
    Nat Commun; 2024 Mar; 15(1):2370. PubMed ID: 38499542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.
    Shi K; Demir Ö; Carpenter MA; Wagner J; Kurahashi K; Harris RS; Amaro RE; Aihara H
    Sci Rep; 2017 Dec; 7(1):17415. PubMed ID: 29234087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
    Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
    Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOBEC3B: pathological consequences of an innate immune DNA mutator.
    Burns MB; Leonard B; Harris RS
    Biomed J; 2015; 38(2):102-10. PubMed ID: 25566802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
    Buisson R; Lawrence MS; Benes CH; Zou L
    Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting natural splicing plasticity of APOBEC3B restricts its expression and mutagenic activity.
    Rouf Banday A; Onabajo OO; Lin SH; Obajemu A; Vargas JM; Delviks-Frankenberry KA; Lamy P; Bayanjargal A; Zettelmeyer C; Florez-Vargas O; Pathak VK; Dyrskjøt L; Prokunina-Olsson L
    Commun Biol; 2021 Mar; 4(1):386. PubMed ID: 33753867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.
    Matsumoto T; Shirakawa K; Yokoyama M; Fukuda H; Sarca AD; Koyabu S; Yamazaki H; Kazuma Y; Matsui H; Maruyama W; Nagata K; Tanabe F; Kobayashi M; Shindo K; Morishita R; Sato H; Takaori-Kondo A
    Sci Rep; 2019 Jun; 9(1):8307. PubMed ID: 31165764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases.
    Wong L; Sami A; Chelico L
    Nucleic Acids Res; 2022 Nov; 50(21):12039-12057. PubMed ID: 36444883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
    Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.
    Seplyarskiy VB; Soldatov RA; Popadin KY; Antonarakis SE; Bazykin GA; Nikolaev SI
    Genome Res; 2016 Feb; 26(2):174-82. PubMed ID: 26755635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.
    Caval V; Suspène R; Shapira M; Vartanian JP; Wain-Hobson S
    Nat Commun; 2014 Oct; 5():5129. PubMed ID: 25298230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.
    Ooms M; Krikoni A; Kress AK; Simon V; Münk C
    J Virol; 2012 Jun; 86(11):6097-108. PubMed ID: 22457529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.
    Akre MK; Starrett GJ; Quist JS; Temiz NA; Carpenter MA; Tutt AN; Grigoriadis A; Harris RS
    PLoS One; 2016; 11(5):e0155391. PubMed ID: 27163364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.
    McCann JL; Cristini A; Law EK; Lee SY; Tellier M; Carpenter MA; Beghè C; Kim JJ; Sanchez A; Jarvis MC; Stefanovska B; Temiz NA; Bergstrom EN; Salamango DJ; Brown MR; Murphy S; Alexandrov LB; Miller KM; Gromak N; Harris RS
    Nat Genet; 2023 Oct; 55(10):1721-1734. PubMed ID: 37735199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOBEC3B cytidine deaminase targets the non-transcribed strand of tRNA genes in yeast.
    Saini N; Roberts SA; Sterling JF; Malc EP; Mieczkowski PA; Gordenin DA
    DNA Repair (Amst); 2017 May; 53():4-14. PubMed ID: 28351647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.
    Fu Y; Ito F; Zhang G; Fernandez B; Yang H; Chen XS
    Biochem J; 2015 Oct; 471(1):25-35. PubMed ID: 26195824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.